Yang, Ruige published the artcileSemisynthesis and neurotrophic activity studies of novel neomajucin/majucin derivatives as neurotrophin small molecule mimetics, Recommanded Product: 4-Methoxyphenylacetic acid, the main research area is neurotrophin small mol mimetic neomajucin majucin ester neurotrophic agent; Illicium sesquiterpenes; Majucin; Neomajucin; Neuroprotective effect; Structure–activity relationship.
Majucin-type Illicium sesquiterpenes with potent neurotrophic activity are considered to be promising candidates for the treatment of various neurodegenerative disease. Owing to the low-abundance metabolites in Illicium genus, there are few studies on their structural modifications, structure-activity relationships, and pharmacophoric motif. Herein, structural modifications were conducted on the hydroxyl groups at C-3 and C-6 positions of two majucin-type compounds neomajucin (1, I) and majucin (2, II), and 39 neomajucin/majucin based esters were synthesized and evaluated for their neurite outgrowth-promoting activities. Many of the target derivatives displayed more potent neurite outgrowth-promoting activity than their precursors. Some interesting structure-activity relationships (SARs) were also observed Moreover, compound 1a (III) showed good neuroprotective effect on MPP+-induced PC12 cell damage. Finally, compounds 1a and 3a (IV) exhibited relatively no cytotoxicity to normal human H9C2 cardiac cells. This work will shed light on the development of neomajucin/majucin derivatives as potential neurotrophic agents.
Bioorganic & Medicinal Chemistry Letters published new progress about Drug safety. 104-01-8 belongs to class isoquinoline, name is 4-Methoxyphenylacetic acid, and the molecular formula is C9H10O3, Recommanded Product: 4-Methoxyphenylacetic acid.
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem